This article first appeared on GuruFocus.Bristol Myers Squibb (NYSE:BMY), a drugmaker focused on creating new medicines, is expanding its three-year partnership with Nvidia, a chipmaker providing artificial intelligence computing technology, to increase the power of its AI factory.…
Back to News
AI
Bristol Myers Expands NVIDIA Partnership to Build Top Life Sciences AI Supercomputer
Biztoc.com·July 20, 2026
AI Summary
Bristol Myers Squibb is expanding its partnership with NVIDIA to build a supercomputer dedicated to artificial intelligence applications in life sciences and drug discovery. The collaboration aims to leverage NVIDIA's AI computing technology to accelerate the development of new medicines.
Full story reconstructed from Biztoc.com. Formatting and media may differ from the original.
View original at Biztoc.comWas this useful?